Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Contact Us

Real-World Utilization of a Multi-Proteomic, Serum-Based Assay for Assessing Response to Therapy in Persons with Multiple Sclerosis

September 27, 2024inByCommentNo Comments
Click here

© 2025 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us